Loading

GU Oncology Now Journal

A monthly publication highlighting original articles and interviews.

Rectal Spacing Techniques Improve Outcomes in Patients With Prostate Cancer

It is estimated that prostate cancer will be diagnosed in nearly 268,000 men in 2022, making it the most commonly diagnosed cancer in men.1 Radiation therapy and surgical therapy are typically the primary treatment options for patients with prostate cancer. Options for radiation treatment include external beam radiation therapy (EBRT) and brachytherapy, wherein radioactive seeds are implanted into the prostate gland. EBRT has several modalities, based on regimen, with hypofractionated regimens called stereotactic beam radiation therapy (SBRT) delivering therapy over the shortest time. ...

Advertisement

Articles from the Latest Issue

Akhil Abraham Saji, MD

Journal | August 24, 2022

A review of a series of articles published by Urology on diversity, equity, and inclusion findings in prostate cancer care.

David Ambinder, MD

Journal | August 24, 2022

Studies on the use of cytoreductive nephrectomy in mRCC are reviewed, including its role among TKIs and immunotherapy.

Daniel Tennenbaum, MD

Journal | August 24, 2022

A report examines the correlation between family history of prostate cancer and risk of progression after prostatectomy.

David Ambinder, MD

Journal | August 24, 2022

Dr. Stacy Loeb is interviewed on the use of active surveillance for prostate cancer, its history, and new insights.

Linda Brookes, MSc

Journal | August 24, 2022

Catherine Handy Marshall reviews her career from cardiovascular disease research to prostate cancer risk factors & genetics.

David Ambinder, MD

Journal | August 24, 2022

The utility of using AI to help determine scoring and surgical options for kidney cancer is examined against human scoring.

Advertisement

Browse Our Past Issues

Advertisement
Advertisement
Editorial Advisory Board